Learn More About the PROSERA Study
Now enrolling: The PROSERA phase 3 study of seralutinib in adults with pulmonary arterial hypertension.
Phase 1 Drug-Drug Interaction Studies of Inhaled Seralutinib in Healthy Subjects
